Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sevasemten
DRUG
3 trials
Sponsors
Edgewise Therapeutics, Inc.
Conditions
Becker Muscular Dystrophy
Healthy Subjects
Phase 1
A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
Completed
NCT05160415
Edgewise Therapeutics, Inc.
Becker Muscular Dystrophy
Start: 2021-12-28
End: 2024-03-01
Updated: 2025-06-24
A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
Completed
NCT06916897
Edgewise Therapeutics, Inc.
Healthy Subjects
Start: 2025-01-08
End: 2025-02-22
Updated: 2025-04-08
Phase 2
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Enrolling by invitation
NCT06066580
Edgewise Therapeutics, Inc.
Becker Muscular Dystrophy
Start: 2023-11-02
End: 2031-02-01
Target: 260
Updated: 2026-09-17
Related Papers
Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label study.
2026-06-17